EUVIMEDOpdag EUVIMED
Multizentrische StudieKlinische Studie

Impact of Constipation Therapies on Severity of Gastroparesis and Constipation Symptoms in Relation to Gastric and Colonic Transit

Brian C Surjanhata iD, Baharak Moshiree iD, Allen A Lee, Richard W McCallum iD, Irene Sarosiek iD, Linda A Nguyen iD, Michael I Schulman, John M Wo iD, Henry P Parkman iD, Braden Kuo, William L Hasler, Satish S C Rao iD

Neurogastroenterology & Motility · 2025

DOI: 10.1111/nmo.70013 ↗

At a glance

Multizentrische Studie in Neurogastroenterology & Motility, 2025. Written by Brian C Surjanhata and 11 co-authors. Institution: Center for Neurointestinal Health, Gastroenterology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA. Major MEDLINE topics: Constipation, Gastrointestinal Transit, Gastroparesis, Laxatives. Cited 4 times so far (Crossref); 40 references. Funded by: Medtronic.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Introduction

Studies demonstrate an overlap of constipation with gastroparesis and functional dyspepsia, but the impact of treatments that target constipation on improving upper gastrointestinal (UGI) symptoms is unexplored. We quantified the effects of constipation medication therapies on UGI and constipation symptom severity in subjects presenting with symptoms of gastroparesis.

Methods

Fifty‐six subjects with symptoms of gastroparesis underwent concurrent wireless motility capsule and gastric emptying scintigraphy and were recommended to receive either a new medication therapy for constipation or a change in constipation therapy based on investigator interpretation of test results. Gastroparesis Cardinal Symptom Index (GCSI), upper abdominal pain, and constipation scores were compared between baseline and 6 months. Data were compared between delayed or non‐delayed gastric emptying and the presence or absence of slow colonic transit. Key Results Subjects with slow colonic transit had improvements in GCSI ( p = 0.007) and constipation scores ( p = 0.004) after treatment with a new or changed constipation medication, with the delayed emptying subgroup driving GCSI improvements ( p = 0.004). Reductions in nausea/vomiting ( p = 0.02) and early satiety/fullness subscores ( p = 0.002) with trends to improved bloating/distention subscores ( p = 0.06) were observed in this subgroup, but upper abdominal pain was unchanged. Subjects with normal colonic transit showed no improvement in GCSI scores regardless of gastric emptying status ( p > 0.05). Conclusions and Inferences Identifying and treating delayed colonic transit in gastroparetic (delayed gastric emptying) subjects improves global UGI symptoms as well as selected individual symptoms. Evaluation of whole gut motility as well as recognizing and managing extragastric delay may promote improved outcomes in these patients. Trial Registration ClinicalTrials.gov : NCT02022826

Subjects

MeSH terms (MEDLINE)

ConstipationGastrointestinal TransitGastroparesisLaxativesAdultAgedFemaleHumansMaleMiddle AgedGastric EmptyingSeverity of Illness IndexTreatment Outcome

Author keywords

constipation treatmentdyspepsiagastric emptyingslow transit constipationsymptom outcomeswireless motility capsule

Substances

Laxatives

Authors and institutions

  • Center for Neurointestinal Health, Gastroenterology Unit, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Atrium Health Wake Forest Baptist, Morehead Medical Plaza, Charlotte, North Carolina, USA.
  • Division of Gastroenterology, University of Michigan Health System, Ann Arbor, Michigan, USA.
  • Section of Gastroenterology, Texas Tech University, El Paso, Texas, USA.
  • Division of Gastroenterology, Stanford University, Palo Alto, California, USA.
  • Florida Digestive Health Associates, Largo, Florida, USA.

ORCID profiles: Brian C Surjanhata, Baharak Moshiree, Richard W McCallum, Irene Sarosiek, Linda A Nguyen, John M Wo, Henry P Parkman, Satish S C Rao

Funding

  • Medtronic

Cite

APA

Surjanhata, B. C., Moshiree, B., Lee, A. A., McCallum, R. W., Sarosiek, I., Nguyen, L. A., Schulman, M. I., Wo, J. M., Parkman, H. P., Kuo, B., Hasler, W. L., & Rao, S. S. C. (2025). Impact of Constipation Therapies on Severity of Gastroparesis and Constipation Symptoms in Relation to Gastric and Colonic Transit. Neurogastroenterology & Motility. https://doi.org/10.1111/nmo.70013

Vancouver

Surjanhata BC, Moshiree B, Lee AA, McCallum RW, Sarosiek I, Nguyen LA, et al. Impact of Constipation Therapies on Severity of Gastroparesis and Constipation Symptoms in Relation to Gastric and Colonic Transit. Neurogastroenterology & Motility. 2025. doi:10.1111/nmo.70013

BibTeX
@article{Surjanhata2025,
  author = {Surjanhata, Brian C and Moshiree, Baharak and Lee, Allen A and McCallum, Richard W and Sarosiek, Irene and Nguyen, Linda A and Schulman, Michael I and Wo, John M and Parkman, Henry P and Kuo, Braden and Hasler, William L and Rao, Satish S C},
  title = {Impact of Constipation Therapies on Severity of Gastroparesis and Constipation Symptoms in Relation to Gastric and Colonic Transit},
  journal = {Neurogastroenterology & Motility},
  year = {2025},
  doi = {10.1111/nmo.70013}
}
Start for free →